ASSESSMENT OF DOPAMINERGIC RESPONSE IN PARKINSONS-DISEASE USING THE APOMORPHINE TEST

被引:0
|
作者
MIRANDA, M [1 ]
SAEZ, D [1 ]
机构
[1] HOSP CLIN FELIX BULNES, UNIDAD NEUROL, SANTIAGO, CHILE
关键词
PARKINSON DISEASE; DOPAMINE APOMORPHINE; DIAGNOSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apomorfine is a potent dopaminergic agonist that quickly and predictably reverts parkinsonian symtomatology. In 32 patients (18 male) aged 45 to 83 years old (22 with idiopathic parkinsonism and 10 with parkinsonism of other causes), the dopaminergic response to apomorphine after domperidone administration was assessed using the digital skill test and Webster scale. Twenty patients with idiopathic parkinsonism and 1 with parkinsonism of other causes had a positive response to apomorphine. In 44% apomorphine had adverse effects. All patients with idiopathic parkinsonism and the only patient with parkinsonism of other causes with a positive apomorphine test had a good response to levodopa therapy. It is concluded that apomorphine test has a 95% positive predictive value for idiopathic parkinsonism and is a useful diagnostic tool.
引用
收藏
页码:326 / 329
页数:4
相关论文
共 50 条
  • [21] THE CLINICAL USE OF APOMORPHINE IN PARKINSONS-DISEASE
    STEIGER, MJ
    QUINN, NP
    MARSDEN, CD
    JOURNAL OF NEUROLOGY, 1992, 239 (07) : 389 - 393
  • [22] DOPAMINERGIC RESPONSIVENESS TO APOMORPHINE AFTER CHRONIC TREATMENT WITH SUBCUTANEOUS LISURIDE INFUSION IN PARKINSONS-DISEASE
    VAAMONDE, J
    LUQUIN, MR
    OBESO, JA
    MOVEMENT DISORDERS, 1990, 5 (03) : 260 - 262
  • [23] TRH TEST AND THE CONTINUOUS DOPAMINERGIC STIMULATION IN COMPLICATED PARKINSONS-DISEASE
    LESTINGI, L
    BONIFATI, V
    STOCCHI, F
    ANTONOZZI, I
    MECO, G
    EUROPEAN NEUROLOGY, 1992, 32 (02) : 65 - 69
  • [24] MOTOR RESPONSE FOLLOWING REPEATED APOMORPHINE ADMINISTRATION IS REDUCED IN PARKINSONS-DISEASE
    GRANDAS, F
    OBESO, JA
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (01) : 14 - 22
  • [25] CHALLENGE TESTS TO PREDICT THE DOPAMINERGIC RESPONSE IN UNTREATED PARKINSONS-DISEASE
    HUGHES, AJ
    LEES, AJ
    STERN, GM
    NEUROLOGY, 1991, 41 (11) : 1723 - 1725
  • [26] INTRANASAL APOMORPHINE - A NEW TREATMENT IN PARKINSONS-DISEASE
    KAPOOR, R
    TURJANSKI, N
    FRANKEL, J
    KLEEDORFER, B
    LEES, A
    STERN, G
    BOVINGDON, M
    WEBSTER, R
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (11): : 1015 - 1015
  • [27] APOMORPHINE FOR MOTOR FLUCTUATIONS AND FREEZING IN PARKINSONS-DISEASE
    CORBOY, DL
    WAGNER, ML
    SAGE, JI
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (03) : 282 - 288
  • [28] EFFECTS OF APOMORPHINE ON SWALLOWING AND DEFECATION IN PARKINSONS-DISEASE
    PFEIFFER, RF
    EDWARDS, LL
    HARNED, RK
    QUIGLEY, EMM
    HOFMAN, R
    ANNALS OF NEUROLOGY, 1992, 32 (02) : 276 - 276
  • [29] EFFECTS OF APOMORPHINE ON THE BLADDER OF PATIENTS WITH PARKINSONS-DISEASE
    ARANDA, B
    CRAMER, P
    ADBA, MA
    JOURNAL D UROLOGIE, 1992, 98 (01) : 25 - 29
  • [30] CONTINUOUS SUBCUTANEOUS APOMORPHINE INFUSION IN PARKINSONS-DISEASE
    SIMPKIN, DM
    MILNER, R
    SNELL, APJ
    MEDICAL JOURNAL OF AUSTRALIA, 1992, 156 (12) : 883 - 884